These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8746772)

  • 1. Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?
    Krieg AM; Stein CA
    Antisense Res Dev; 1995; 5(4):241. PubMed ID: 8746772
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
    Agrawal S
    Biochim Biophys Acta; 1999 Dec; 1489(1):53-68. PubMed ID: 10806997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90.
    Watanabe N; Sawai H; Endo K; Shinozuka K; Ozaki H; Tanada S; Murata H; Sasaki Y
    Nucl Med Biol; 1999 Feb; 26(2):239-43. PubMed ID: 10100225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of synthetic phosphorothioate oligonucleotides from phosphodiester-defect species by strong-anion exchange HPLC.
    Bergot BJ; Zon G
    Ann N Y Acad Sci; 1992 Oct; 660():310-2. PubMed ID: 1340142
    [No Abstract]   [Full Text] [Related]  

  • 5. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides.
    Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M
    Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of diastereomeric ratios of deoxyribonucleoside phosphoramidites on the synthesis of phosphorothioate oligonucleotides.
    Cheruvallath ZS; Sasmor H; Cole DL; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2000 Mar; 19(3):533-43. PubMed ID: 10843490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.
    Peng Ho S; Livanov V; Zhang W; Li J; Lesher T
    Brain Res Mol Brain Res; 1998 Nov; 62(1):1-11. PubMed ID: 9795101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides.
    Stein CA; Krieg AM
    Antisense Res Dev; 1994; 4(2):67-9. PubMed ID: 7950301
    [No Abstract]   [Full Text] [Related]  

  • 9. A semi-empirical Hückel molecular orbital analysis of internucleotide phosphorothioate diesters.
    Weltman JK; Karim AS
    Anticancer Res; 1998; 18(4A):2733-6. PubMed ID: 9703937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups.
    MacKellar C; Graham D; Will DW; Burgess S; Brown T
    Nucleic Acids Res; 1992 Jul; 20(13):3411-7. PubMed ID: 1630912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transforming growth factor-beta 2 expression with phosphorothioate antisense oligonucleotides in U937 cells.
    Shen ZJ; Kim SK; Lee YS; Lee JW; Moon BJ
    Bioorg Med Chem Lett; 1999 Jan; 9(1):13-8. PubMed ID: 9990448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in antisense therapeutics discovery and development.
    Crooke ST
    Ciba Found Symp; 1997; 209():158-64; discussion 164-8. PubMed ID: 9383575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel universal linker for efficient synthesis of phosphorothioate oligonucleotides.
    Wang Z; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):259-69. PubMed ID: 17454735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
    Lund OS; Nielsen JO; Hansen JE
    Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake, distribution, and degradation of phosphorothioate oligonucleotides in Euplotes crassus.
    Thomas LL; Price CM
    Ann N Y Acad Sci; 1992 Oct; 660():328-30. PubMed ID: 1340149
    [No Abstract]   [Full Text] [Related]  

  • 16. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines.
    Agrawal S; Tan W; Cai Q; Xie X; Zhang R
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):245-9. PubMed ID: 9212919
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation and characterization of diastereoisomeric oligonucleotide.
    Murakami A; Tamura Y; Nishi M; Morii T; Ide H; Makino K
    Nucleic Acids Symp Ser; 1992; (27):137-8. PubMed ID: 1289793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of chimeric oligonucleotides containing phosphodiester, phosphorothioate, and phosphoramidate linkages.
    Maier MA; Guzaev AP; Manoharan M
    Org Lett; 2000 Jun; 2(13):1819-22. PubMed ID: 10891166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of oligonucleotides.
    Agrawal S; Zhang R
    Ciba Found Symp; 1997; 209():60-75; discussion 75-8. PubMed ID: 9383569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.